Prevention of Inflammatory Bowel Diseases in Persons at Risk The PIONIR (Preventing IBD Onset in Individuals at Risk) Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Inflammatory Bowel Diseases
Interventions
OTHER

Tasty&Healthy

exclude pro-inflammatory dietary components

OTHER

Habitual diet

subjects will continue their habitual diet.

Trial Locations (1)

Unknown

Shaare Zedek Medical Center, Jerusalem

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

collaborator

The Hospital for Sick Children

OTHER

collaborator

The Governors of the University of Alberta

UNKNOWN

collaborator

University of Manitoba

OTHER

collaborator

IWK Health Centre

OTHER

collaborator

University of British Columbia

OTHER

collaborator

University of Calgary

OTHER

collaborator

McGill University

OTHER

collaborator

Beilinson Hospital, Petach Tikva,Israel

UNKNOWN

lead

Shaare Zedek Medical Center

OTHER